All In Biotech

Drug Trial Radar · NCT04968912

A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 163 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

163

Actual

Start

Sep 21, 2021

Primary completion

Oct 23, 2023

Study completion Nov 30, 2023

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Jul 20, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of nipocalimab in participants with primary Sjogren's syndrome (pSS) versus placebo.

Conditions

  • Sjogren's Syndrome

Interventions

  • PlaceboOther

    Placebo infusion will be administered intravenously.

  • NipocalimabDrug

    Nipocalimab dose 1 and dose 2 infusions will be administered intravenously.

  • Standard of Care TreatmentDrug

    Standard of care treatment including ophthalmic drops, artificial tears and saliva, punctum plugs, and secretagogues, and/or one immunomodulator with or without low-dose glucocorticosteroids will be administered topically/orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Clinical European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease Activity Index (clinESSDAI) Score at Week 24Time frame: Baseline (Week 0), Week 24

Locations

69 sites in 10 countries. Site status is shown where the registry gives one.

  • Anniston Medical Clinic

    Anniston, Alabama

  • Arizona Arthritis and Rheumatology Research PLLC

    Glendale, Arizona

  • Arizona Arthritis & Rheumatology Research, PLLC

    Mesa, Arizona

  • St. Jude Heritage Medical Group

    Fullerton, California

  • Inland Rheumatology Clinical Trials, Inc.

    Upland, California

  • Colorado Arthritis Associates

    Denver, Colorado

  • Denver Arthritis Clinic

    Denver, Colorado

  • Rheumatology Associates Of South Florida

    Boca Raton, Florida

  • Bay Area Arthritis and Osteoporosis

    Brandon, Florida

  • Centre for Rheumatology, Immunology and Arthritis

    Fort Lauderdale, Florida

  • University of Florida Health Jacksonville

    Jacksonville, Florida

  • Omega Research Consultants

    Orlando, Florida

  • Clinical Investigation Specialists

    Gurnee, Illinois

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • University of Kansas Medical Center

    Kansas City, Kansas

  • St. Paul Rheumatology P A

    Eagan, Minnesota

  • North Mississippi Medical Clinics

    Tupelo, Mississippi

  • PMG Research of Salisbury

    Salisbury, North Carolina

  • Altoona Center For Clinical Research

    Duncansville, Pennsylvania

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Columbia Arthritis Center

    Columbia, South Carolina

  • West Tennessee Research Institute

    Jackson, Tennessee

  • Dr. Ramesh Gupta

    Memphis, Tennessee

  • Austin Regional Clinic

    Austin, Texas

  • Trinity Clinical Research, LLC

    Carrollton, Texas

  • CHU de Grenoble Hopital Albert Michallon

    La Tronche, France

  • Centre Hospitalier Le Mans

    Le Mans, France

  • Hopital Saint Joseph

    Marseille, France

  • Hopital Pitie Salpetriere

    Paris, France

  • CHRU Hôpital de Hautepierre

    Strasbourg, France

  • Charite Universitaetsmedizin Berlin

    Berlin, Germany

  • Uniklinik Köln

    Cologne, Germany

  • Universitatsklinikum Carl Gustav Carus Dresden

    Dresden, Germany

  • Hamburger Rheuma Forschungszentrum II

    Hamburg, Germany

  • medius KLINIK KIRCHHEIM

    Kirchheim unter Teck, Germany

  • Universitatsklinikum Tubingen

    Tübingen, Germany

  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Presidio Spedali Civili

    Brescia, Italy

  • P.O. Vittorio Emanuele Azienda Ospedaliero Universitaria 'Policlinico Vittorio Emanuele'

    Catania, Italy

  • IRCCS Ospedale San Raffaele

    Milan, Italy

  • Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone

    Palermo, Italy

Showing 40 of 69 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.